Showing results (181-190 of 318) with videos related to

Sort By:
Pageof 32
Journal of Ethnopharmacology|April 26, 2023
Inhibitory and in silico molecular docking of Xeroderris stuhlmannii (Taub.) Mendonca & E.P. Sousa phytochemical compounds on human α-glucosidasesBrilliant Nyathi, Jonathan Tatenda Bvunzawabaya, Chido Venissa P Mudawarima, et al.
Experimental Hematology|February 21, 2007
Stem cell transplantation demonstrates that Sox6 represses epsilon y globin expression in definitive erythropoiesis of adult miceOrit Cohen-Barak, Drew T Erickson, Michael S Badowski, et al.
Cancer Research|December 3, 2005
Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomasNikia A Laurie, Meghan M Comegys, Marie P Carreiro, et al.
JACC. Case Reports|December 18, 2024
Neutral Lipid Storage Disease With Myopathy and Infiltrative Cardiomyopathy Initially Presenting as Right Arm WeaknessJustin Brilliant, Christopher Krogh, Diljon Chahal, et al.
Journal of the American Optometric Association|July 1, 1993
Use of spectacle mounted telescope systems by the visually impairedH A Greene, J Pekar, R Brilliant, et al.
European Journal of Human Genetics : EJHG|July 31, 2014
Phenome-wide association studies (PheWASs) for functional variantsZhan Ye, John Mayer, Lynn Ivacic, et al.
Clinical & Experimental Ophthalmology|March 20, 2014
Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trialC Gail Summers, John E Connett, Ann M Holleschau, et al.
The Journal of Arthroplasty|April 23, 2023
Complication Rate After Primary Total Hip Arthroplasty Using the Posterior Approach and Enabling Technology: A Consecutive Series of 2,888 HipsChristopher G Anderson, Seong J Jang, Zachary R Brilliant, et al.
The Journal of Arthroplasty|March 1, 2023
Deep Learning Phenotype Automation and Cohort Analyses of 1,946 Knees Using the Coronal Plane Alignment of the Knee ClassificationJohn R Steele, Seong Jun Jang, Zachary R Brilliant, et al.
BMC Cancer|October 9, 2013
RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patientsSam Cross-Knorr, Shaolei Lu, Kimberly Perez, et al.
Pageof 32